These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1986099)

  • 41. Therapeutic efficacy of interferon alfa-2a and 13-cis-retinoic acid in recurrent angiosarcoma of the head.
    Spieth K; Gille J; Kaufmann R
    Arch Dermatol; 1999 Sep; 135(9):1035-7. PubMed ID: 10490107
    [No Abstract]   [Full Text] [Related]  

  • 42. Kasabach-Merritt syndrome: a case review.
    Szlachetka DM
    Neonatal Netw; 1998 Feb; 17(1):7-15. PubMed ID: 9526357
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial.
    Solomon T; Dung NM; Wills B; Kneen R; Gainsborough M; Diet TV; Thuy TT; Loan HT; Khanh VC; Vaughn DW; White NJ; Farrar JJ
    Lancet; 2003 Mar; 361(9360):821-6. PubMed ID: 12642049
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kasabach-Merrit syndrome in infants.
    Sarihan H; Mocan H; Abeys M; Akyazici R; Cay A; Imamoğlu M
    Panminerva Med; 1998 Jun; 40(2):128-31. PubMed ID: 9689834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Kasabach-Merritt syndrome: treatment with intermittent pneumatic compression.
    Aylett SE; Williams AF; Bevan DH; Holmes SJ
    Arch Dis Child; 1990 Jul; 65(7):790-1. PubMed ID: 2386388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of a testicular haemangioma after interferon therapy for hepatic haemangiomas: a case report.
    Yanai S; Tsutsumi H; Hotsubo T; Takahashi A; Miyao N; Satoh M; Chiba S
    Eur J Pediatr; 1997 Oct; 156(10):784-6. PubMed ID: 9365068
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interferon therapy in an infant with Kasabach-Merritt syndrome.
    Yeh KW; Jiang TH; Hung IJ
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(5):368-72. PubMed ID: 8607364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group study.
    Kelly K; Crowley JJ; Bunn PA; Hazuka MB; Beasley K; Upchurch C; Weiss GR; Hicks WJ; Gandara DR; Rivkin S
    J Clin Oncol; 1995 Dec; 13(12):2924-30. PubMed ID: 8523056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analyses.
    Creagan ET; Ahmann DL; Frytak S; Long HJ; Chang MN; Itri LM
    Cancer; 1987 Feb; 59(3 Suppl):638-46. PubMed ID: 10822463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regression of infancy hemangiomas with recombinant IFN-alpha 2b.
    Garmendía G; Miranda N; Borroso S; Longchong M; Martínez E; Ferrero J; Porrero P; López-Saura P
    J Interferon Cytokine Res; 2001 Jan; 21(1):31-8. PubMed ID: 11177578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Therapeutic possibilities of recombinant interferon alfa-2b (Intron A) in non-AIDS Kaposi sarcomas and angiosarcomas].
    Jelić S; Vuletić L; Filipović I; Milanović N; Tomasević Z; Marinković M
    Glas Srp Akad Nauka Med; 1994; (44):117-25. PubMed ID: 7590408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Case report: Kasabach-Merritt syndrome: a review of the therapeutic options and a case report of successful treatment with radiotherapy and interferon alpha.
    Hesselmann S; Micke O; Marquardt T; Baas S; Bramswig JH; Harms E; Willich N
    Br J Radiol; 2002 Feb; 75(890):180-4. PubMed ID: 11893644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie.
    Negrier S; Escudier B; Lasset C; Douillard JY; Savary J; Chevreau C; Ravaud A; Mercatello A; Peny J; Mousseau M; Philip T; Tursz T
    N Engl J Med; 1998 Apr; 338(18):1272-8. PubMed ID: 9562581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Caution in regard to treatment of hemangiomas with interferon alfa-2a.
    Vora AJ; Lilleyman JS
    N Engl J Med; 1992 Oct; 327(18):1321-2. PubMed ID: 1489461
    [No Abstract]   [Full Text] [Related]  

  • 56. Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases.
    Melikyan AL; Subortseva IN; Gilyazitdinova EA; Koloshejnova TI; Pustovaya EI; Egorova EK; Kovrigina AM; Sudarikov AB; Abdullaev AO; Lomaia EG; Siordiya NT; Zaritskey AY; Savchenko VG
    Ter Arkh; 2018 Aug; 90(7):23-29. PubMed ID: 30701919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase II evaluation of recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated metastatic colorectal adenocarcinoma.
    Pazdur R; Ajani JA; Patt YZ; Gomez J; Bready B; Levin B
    Cancer; 1993 Feb; 71(4):1214-8. PubMed ID: 8435795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Which hemangiomas to treat--and how?
    Frieden IJ
    Arch Dermatol; 1997 Dec; 133(12):1593-5. PubMed ID: 9420551
    [No Abstract]   [Full Text] [Related]  

  • 59. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.
    Escudier B; Pluzanska A; Koralewski P; Ravaud A; Bracarda S; Szczylik C; Chevreau C; Filipek M; Melichar B; Bajetta E; Gorbunova V; Bay JO; Bodrogi I; Jagiello-Gruszfeld A; Moore N;
    Lancet; 2007 Dec; 370(9605):2103-11. PubMed ID: 18156031
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pulmonary capillary hemangiomatosis associated with primary pulmonary hypertension: report of 2 new cases and review of 35 cases from the literature.
    Almagro P; Julià J; Sanjaume M; González G; Casalots J; Heredia JL; Martínez J; Garau J
    Medicine (Baltimore); 2002 Nov; 81(6):417-24. PubMed ID: 12441898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.